事業提携・ライセンシング・投資・M&A動向(四半期別):Q4 2012...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2012 8
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2012 8
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2012 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2012 11
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2012 12
2.4.1 Abbott Completes Private Placement of Notes for $14.7 Billion 12
2.4.2 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion 12
2.4.3 UnitedHealth Group to Acquire 90% Stake in Amil Participacoes for $4.9 Billion 12
2.4.4 HCA Completes Public Offering of Notes for $3.5 Billion 13
2.4.5 HCP Completes Acquisition of Senior Housing Portfolio of Emeritus and Blackstone for $1.7 Billion 13
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2012 14
3.1.1 Top M&A Deals in Q4 2012 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2011 – Q4 2012 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2012 17
3.2.1 Top Initial Public Offerings in Q4 2012 18
3.2.2 Top Secondary Offerings in Q4 2012 18
3.2.3 Top PIPE Deals in Q4 2012 18
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2011–Q4 2012 19
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2011 – Q4 2012 20
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2012 21
3.3.1 Top Venture Financing Deals in Q4 2012 22
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2012 23
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2012 24
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2011 – Q4 2012 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 26
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 27
3.3.7 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2012 28
3.3.8 Top Private Equity Deals in Q4 2012 29
3.3.9 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2011 – Q4 2012 30
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2012 31
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2012 31
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2011 – Q4 2012 33
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 34
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2012 35
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2012 35
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2012 36
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 37
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2011 – Q4 2012 38
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2011 – Q4 2012 39
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 40
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2012 41
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2012 41
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 42
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2012 43
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2012 43
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2012 44
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2011 – Q4 2012 45
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2011 – Q4 2012 46
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2011 – Q4 2012 47
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2011 – Q4 2012 48
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2011 – Q4 2012 49
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 50
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2011 – Q4 2012 50
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2011 – Q4 2012 51
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2011 – Q4 2012 52
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2011 – Q4 2012 53
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2011 – Q4 2012 54
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2011 – Q4 2012 55
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2011 – Q4 2012 56
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 57
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2012 57
7.1.1 Oncology – Deals of the Quarter 58
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2012 59
7.2.1 Central Nervous System – Deals of the Quarter 60
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2012 62
7.3.1 Infectious Disease – Deals of the Quarter 63
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2012 64
7.4.1 Immunology – Deals of the Quarter 65
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2012 66
7.5.1 Metabolic Disorders – Deals of the Quarter 67
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2012 68
7.6.1 Cardiovascular – Deals of the Quarter 69
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2012 70
7.7.1 Gastrointestinal – Deals of the Quarter 71
7.8 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2012 72
7.8.1 Ophthalmology – Deals of the Quarter 73
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2012 74
7.9.1 Respiratory – Deals of the Quarter 75
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2012 76
7.10.1 Dermatology – Deals of the Quarter 77
8 Deal Summary by Geography 78
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2012 78
8.1.1 North America – Deals of the Quarter 79
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2012 81
8.2.1 Europe – Deals of the Quarter 82
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2012 83
8.3.1 Asia-Pacific – Deals of the Quarter 84
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2012 85
8.4.1 Rest of the World – Deals of the Quarter 86
9 Pharmaceuticals & Healthcare, Global, Top Advisors 87
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 87
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 88
10 Appendix 89
11 Further Information 93
11.1 Methodology 93
11.2 About GlobalData 93
11.3 Contact Us 94
11.4 Disclosure information 94
11.5 Disclaimer 94


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向(四半期別):Q4 2012
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012
■ 発行日:2013年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160305
■ 調査対象地域:グローバル
  • 世界のリーファー輸送市場2013/14
    A global study of this nature is a unique tool that enables you to quickly assess current and future developments with confidence. No other source of information enables you to drill down into specific market attributes with such ease. Drewry Maritime Research’s annual series of reports provide the type of data, analysis and informed comment you need for decision making. Independent in thought the …
  • Questar Corporation:石油・ガスバリューチェーン分析レポート2013
    Questar Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Questar Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Questar Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
  • 世界の調理済食品市場(2012 2016)
    TechNavio's analysts forecast the Global Ready Meals market to grow at a CAGR of 4.69 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing innovation in packaging. The Global Ready Meals market has also been witnessing the increasing concerns of health and wellness among consumers. However, the rising safety issues associated with ready meals …
  • 内視鏡の世界市場:フレキシブル内視鏡、硬性内視鏡、カプセル内視鏡
    The global endoscopy equipment market is segmented on the basis of product and application. By product, the market is categorized into endoscopes, visualization systems, other endoscopy equipment, and accessories. In 2015, the endoscopes segment is estimated to account for the larger share of the market and expected to grow at the fastest rate during the forecast period. The endoscopes market is f …
  • 全身性エリテマトーデス及びループス腎炎:企業と競争環境
    PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Systemic Lupus Erythematosus and Lupus Nephrit …
  • 超音波装置の世界市場:医療診断用超音波装置/治療用超音波装置
    The global ultrasound market is estimated to grow at a CAGR of 5.1% from 2014 to 2019. Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the ultrasound market in 2014, Asia-Pacific is poised to grow at the highest CAGR of 5.5% in the next five years. Factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets …
  • 光触媒ナノコーティングの世界市場
    Photocatalytic self-cleaning coatings are a significant market for nanoparticulate titanium dioxide (TiO2). Nano-TiO2 surfaces (coated with 10-20nm layer of TiO2) are commercially available and have been used in (mainly in the Japanese and European markets) in water and air purification, self-cleaning glass, concrete products and a variety of coatings applications. These coatings greatly benefit b …
  • 世界の産業用電源市場:種類別(AC-DCコンバーター、DC-DCコンバーター、DC-ACインバーター)、出力電力別(低出力(最大1,000 kW)、中出力(1,000 W〜10 kW)、高出力(10〜75 kW)、高出力(75〜150 kW))、業種別、地域別
    The global industrial power supply market is projected to reach USD 12.8 billion by 2024, at a CAGR of 5.4% from 2019 to 2024 The global industrial power supply market size is estimated to be USD 9.9 billion in 2019 and projected to reach USD 12.8 billion by 2024, at a CAGR of 5.4% from 2019 to 2024. The widespread use of consumer electronics and stringent RoHS compliance, as well as the rising de …
  • グローバル公衆安全市場における衛星広帯域通信:Global Satellite Broadband Communication in Public Safety Market 2014-2018
    TechNavio's analysts forecast the Global Satellite Broadband Communication in Public Safety market to grow at a CAGR of 8.45 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for enhanced public safety operations. The Global Satellite Broadband Communication in Public Safety market has also been witnessing the increasing adoption …
  • 世界のIoT(Internet of Things)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Internet of Things market to grow at a CAGR of 32.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing number of connected devices. The Global Internet of Things market has also been witnessing increasing availability of IPv6. However, the security and privacy concerns could pose a challenge to the g …
  • セットトップボックス(STB)の世界市場2015-2019
    About set-top boxes STBs are devices that are connected to TVs to enable users to receive unencrypted subscribed channels through an addressable system for viewing encrypted channels. They connect a TV to an external signal source and transform the transmitted signal into video content, which is then displayed on the screen. STBs can convert both analog and digital signals into visuals. There are …
  • 世界の大型トラック市場
    This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
  • 世界の熱交換器市場
    Heat exchangers are integral part of chemical and petrochemical industries. The chemical industry is the largest user of heat exchanger. Apart from the chemical industry, they are widely used in petrochemical and oil & gas industry, power generation, refrigeration, pharmaceuticals, HVAC, food & beverage processing, and pulp paper industry. New emerging technologies and regulations in certain regio …
  • 胃損傷(Gastric Injury):世界の治験レビュー(2015年上半期版)
    Gastric Injury Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Gastric Injury Global Clinical Trials Review, H1, 2015" provides data on the Gastric Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastric Injury. It includes an overview of the trial numbers and their recruitment status as per …
  • スパッタリング装置の世界市場2017-2021
    About Sputtering Equipment Sputtering is a thin film deposition manufacturing process used in semiconductor, disk drive, CD, and optical device manufacturing industries. The process is performed at the atomic level. The atoms of the source material are bombarded with high energy particles in vacuum. This leads to the deposition of a thin film onto a substrate, which can be a silicon wafer, a solar …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。